Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • Page 854
new-research-suggests-red-light-therapy-may-reduce-blood-clot-risks
Posted inBiotechnology

New Research Suggests Red Light Therapy May Reduce Blood Clot Risks

January 10, 2025
Recent research conducted at the University of Pittsburgh and UPMC has unveiled a remarkable potential therapeutic use for long-wavelength red…
Read More
igm,-y-mabs,-passage-bio-and-more-telegraph-staff-cuts-amid-restructuring-spree
Posted inBiotechnology

IGM, Y-mAbs, Passage Bio and more telegraph staff cuts amid restructuring spree

January 10, 2025
Just two weeks into 2025, January is proving why it’s earned a reputation as the worst month for layoffs. Late…
Read More
4dmt-tosses-2-programs,-halts-funds-for-3-others-as-it-zeroes-in-on-latest-stage-clinical-gene-therapy
Posted inBiotechnology

4DMT tosses 2 programs, halts funds for 3 others as it zeroes in on latest-stage clinical gene therapy

January 10, 2025
4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be…
Read More
kardigan-launches-with-cozy-$300m-series-a-and-collection-of-late-stage-cardio-assets
Posted inBiotechnology

Kardigan launches with cozy $300M series A and collection of late-stage cardio assets

January 10, 2025
A new company is making its debut with a series A sum that’s sure to make hearts race. Launching with…
Read More
abbvie-takes-$3.5b-hit-after-emraclidine’s-phase-2-flop-in-schizophrenia
Posted inBiotechnology

AbbVie takes $3.5B hit after emraclidine’s phase 2 flop in schizophrenia

January 10, 2025
The failure of Cerevel's emraclidine in schizophrenia will cost AbbVie an impairment charge of about $3.5 billion, the pharma said…
Read More
saluda-medical-toasts-$100m-fundraising-to-pep-up-sales-of-its-closed-loop-neurostimulator
Posted inMedical Technology

Saluda Medical toasts $100M fundraising to pep up sales of its closed-loop neurostimulator

January 10, 2025
The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its closed-loop implant aimed…
Read More
revolutionary-self-destructing-vaccine-shows-improved-tuberculosis-protection-in-monkeys
Posted inBiotechnology

Revolutionary Self-Destructing Vaccine Shows Improved Tuberculosis Protection in Monkeys

January 10, 2025
A novel vaccine strategy utilizing a self-destructing strain of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) has shown promising results in combating…
Read More
eli-lilly,-andreessen-horowitz-link-up-on-$500m-biotech-venture-fund
Posted inBiotechnology

Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund

January 10, 2025
Eli Lilly and venture capital firm Andreessen Horowitz (a16z) are joining forces to create a unique new fund dubbed the…
Read More
sustainable-building-features-foster-optimal-indoor-climate
Posted inBiotechnology

Sustainable Building Features Foster Optimal Indoor Climate

January 10, 2025
A groundbreaking advancement in indoor humidity regulation has emerged from ETH Zurich, where a team of researchers has unveiled a…
Read More
study-reveals-brain-differences-associated-with-elevated-disordered-eating-in-young-individuals
Posted inBiotechnology

Study Reveals Brain Differences Associated with Elevated Disordered Eating in Young Individuals

January 10, 2025
A significant finding has emerged from recent research conducted by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s…
Read More

Posts pagination

Previous page 1 … 852 853 854 855 856 … 887 Next page

Privacy Policy    Terms

Scroll to Top